Daniel Moldaver, Seth Anderson, Marguerite Bracher, Roger A Levy, Holly A Quasny, Robert Wood, Rosie Wild, Alexandra Cusmano, Elke Rottier
{"title":"O1 静脉注射贝利木单抗对美国系统性红斑狼疮(SLE)患者类固醇使用和疾病活动的影响:OBSErve研究24个月的结果","authors":"Daniel Moldaver, Seth Anderson, Marguerite Bracher, Roger A Levy, Holly A Quasny, Robert Wood, Rosie Wild, Alexandra Cusmano, Elke Rottier","doi":"10.1136/lupus-2024-el.11","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517941,"journal":{"name":"Oral Presentations","volume":"103 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"O1 Impact of intravenous belimumab treatment on steroid use and disease activity in patients with Systemic Lupus Erythematosus (SLE) in the US in clinical practice: 24-month results from the OBSErve study\",\"authors\":\"Daniel Moldaver, Seth Anderson, Marguerite Bracher, Roger A Levy, Holly A Quasny, Robert Wood, Rosie Wild, Alexandra Cusmano, Elke Rottier\",\"doi\":\"10.1136/lupus-2024-el.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517941,\"journal\":{\"name\":\"Oral Presentations\",\"volume\":\"103 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Presentations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/lupus-2024-el.11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Presentations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2024-el.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
O1 Impact of intravenous belimumab treatment on steroid use and disease activity in patients with Systemic Lupus Erythematosus (SLE) in the US in clinical practice: 24-month results from the OBSErve study